Evaluation of GeneXpert MTB/RIF for detection of Mycobacterium tuberculosis complex and rpo B gene in respiratory and non-respiratory clinical specimens at a tertiary care teaching hospital in Saudi Arabia

References

1. ↵
   1. Ryan GJ,
   2. Shapiro HM,
   3. Lenaerts AJ

   (2014) Improving acid fast fluorescent staining for the detection of mycobacteria using a new nucleic acid staining approach. Tuberculosis (Edinb) 94:511–518.

   OpenUrl
2. ↵
   1. World Health Organization

   (2011) Rapid implementation of the Xpert MTB/RIF diagnostic test (World Health Organization, Geneva).
3. ↵
   1. Division of Microbiology Devices FDA/CDC

   (2015) Revised device labeling for the Cepheid Xpert MTB/RIF assay for detecting Mycobacterial tuberculosis. MMWR Morbidity Mortality Weekly Reports 64:193.

   OpenUrl
4. ↵
   1. World Health Organization

   (2013) Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update (WHO, Geneva).
5. ↵
   1. Steingart KR,
   2. Schiller I,
   3. Horne DJ,
   4. Pai M,
   5. Boehme CC,
   6. Dendukuri N

   (2014) Xpert MTB/RIF assay for pulmonary tuberculosis and rifampin resistance in adults. Cochrane Database Syst Rev (1):CD009593.
6. ↵
   1. McNerney R,
   2. Zumla A

   (2015) Impact of the Xpert MTB/RIF diagnostic test for tuberculosis in countries with a high burden of disease. Curr Opin Pulm Med 21:304–308.

   OpenUrlCrossRefPubMed
7. ↵
   1. Nataraj G,
   2. Kanade S,
   3. Mehta P

   (2016) Xpert MTB/RIF for improved case detection of extra pulmonary TB in a tertiary care setting in urban India. Int J Tuberc Lung Dis 20:890–894.

   OpenUrl
8. ↵
   1. Dekinger CM,
   2. Schumacher SG,
   3. Boehme CC,
   4. Dendukuri N,
   5. Pai M,
   6. Steingart KR

   (2014) Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. Eur Respir J 44:435–446.

   OpenUrlAbstract/FREE Full Text
9. ↵
   1. Al-Ateah SM,
   2. Al-Dowaidi MM,
   3. El-Khizzi NA

   (2012) Evaluation of direct detection of Mycobacterium tuberculosis complex in respiratory and non-respiratory clinical specimens using the Cepheid Gene Xpert®system. Saudi Med J 33:1100–1115.

   OpenUrlPubMedWeb of Science
10. ↵
    1. Bunsow E,
    2. Ruiz-Serrano MJ,
    3. Roa P,
    4. Kestler M,
    5. Viedma D,
    6. Bouza E

    (2014) Evaluation of GeneXpert MTB/RIF for the detection of Mycobacterium tuberculosis and resistance to rifampicin in clinical specimens. J Infect 68:338–343.

    OpenUrlCrossRefPubMed
11. ↵
    1. Maynard-Smith L,
    2. Larke N,
    3. Peters JA,
    4. Lawn SD

    (2014) Diagnostic accuracy of the Xpert MTB/RIF assay for extra-pulmonary and pulmonary tuberculosis when testing non-respiratory samples: a systematic review. BMC Infect Dis 14:709.

    OpenUrlCrossRefPubMed
12. ↵
    1. Kim YW,
    2. Seong MW,
    3. Kim TS,
    4. Yoo CG,
    5. Kim YW,
    6. Han SK,
    7. Yim JJ

    (2015) Evaluation of Xpert MTB/RIF assay: diagnosis and treatment outcomes in Rifampin resistant tuberculosis. Int J Tuberc Lung Dis 19:1261–1221.

    OpenUrl
13. ↵
    1. Neelakantan S,
    2. Nair PP,
    3. Emmanuel RV,
    4. Agarwal K

    (2013) Diversities in presentation of extrapulmonary tuberculosis. BMJ Case Rep 28:2013.

    OpenUrl
14. ↵
    1. Perez-Velez CM,
    2. Marias BJ

    (2012) Tuberculosis in Children. N Engl J Med 367:348–361.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    1. Boyles TH,
    2. Hughes J,
    3. Cox V,
    4. Burton R,
    5. Meintjes G,
    6. Mendelson M

    (2014) False-positive Xpert®MTB/RIF assays in previously treated patients: need for caution in interpreting results. Int J Tuberc Lung Dis 18:876–878.

    OpenUrlCrossRefPubMed